Related Experiment Video

Updated: Oct 2, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular

Andrew R Marks1, Silvia Priori, Mirella Memmi

  • 1Center for Molecular Cardiology, Department of Pharmacology, Box 65, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032, USA. arm42@columbia.edu

Journal of Cellular Physiology
|January 25, 2002
PubMed

Insights

Mutations in the cardiac ryanodine receptor (RyR2) channel are linked to sudden cardiac death (SCD). These RyR2 mutations may cause leaky channels, increasing the risk of fatal arrhythmias during sympathetic stimulation.

Area of Science:

  • Cardiovascular Research
  • Molecular Cardiology
  • Genetics of Cardiac Arrhythmias

Background:

  • The cardiac ryanodine receptor (RyR2) is a key calcium release channel in cardiomyocytes, crucial for heart function.
  • RyR2 dysfunction is implicated in sudden cardiac death (SCD) forms like catecholaminergic polymorphic ventricular tachycardia (CPVT) and arrhythmogenic right ventricular dysplasia type 2 (ARVD2).
  • Eleven missense mutations in RyR2 are associated with these genetic heart diseases.

Purpose of the Study:

  • To investigate the role of RyR2 mutations in catecholaminergic-induced SCD.
  • To explore the mechanism by which RyR2 mutations may lead to increased SR calcium leak.
  • To understand the link between RyR2 mutations and altered channel regulation.

Main Methods:

  • Analysis of RyR2 mutation clustering in regions homologous to skeletal muscle RyR1 (MH/CCD).
  • Review of existing knowledge on RyR2 regulation by protein kinase A (PKA) phosphorylation.
  • Hypothesizing the impact of RyR2 mutations on calcium-induced calcium release and SR calcium leak.

Main Results:

  • RyR2 mutations associated with CPVT/ARVD2 cluster in specific regions homologous to RyR1 mutation sites.
  • PKA phosphorylation normally activates RyR2, but hyperphosphorylation in heart failure leads to leaky channels.
  • SR calcium leak during diastole can trigger delayed afterdepolarizations and fatal arrhythmias.

Conclusions:

  • RyR2 mutations may alter channel regulation, leading to increased SR calcium leak.
  • This increased leak, particularly during sympathetic stimulation, is proposed as a mechanism for catecholaminergic-induced SCD.
  • Understanding these mutations is critical for diagnosing and treating genetic forms of sudden cardiac death.

More Related Videos

Functional Characterization of Endogenously Expressed Human RYR1 Variants07:59

Functional Characterization of Endogenously Expressed Human RYR1 Variants

Published on: June 9, 2021

Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles10:30

Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles

Published on: October 15, 2014

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...